PHOENIX - Officials at the Arizona Research Center are searching for two trials of ALT-711 - an investigational drug used to reverse the effects of hypertension.
There are more than 60 testing sites nationally. Patients recruited will receive ALT-711 tablets or placebo one a day for six months.
To qualify, patients must be 50 years old or older, and have a systolic blood pressure of at least 150 mmHg and a diastolic blood pressure of less than 90 mmHg. Both male and female, diabetic and non-diabetic participants are being recruited.
For more information, contact Brook Irving at: 9602) 863-6363.
Evolving Symptomatology: Respiratory Viruses in the Era of COVID-19 Variants
September 27th 2023As COVID-19 restrictions eased up, other respiratory viruses began circulating alongside SARS-CoV-2. It's crucial to identify cases and understand the symptoms of these infections to track the evolution of the virus and what health care workers should look out for.
Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow
September 15th 2023Plague doctors' historical attire was an early form of PPE. While modern PPE has improved, the quest for better, more comfortable protection continues as we aim for a future where health care workers can provide care confidently.
Adenosine Triphosphate (ATP) Bioluminescence Testing and Performance
September 4th 2023In 2003, the CDC recommended hospitals to clean and disinfect frequently touched surfaces. Later, they advised hospitals to closely supervise cleaning procedures near patients. This article explains what IPC personnel need to know about ATP testing.
2 Clarke Drive
Cranbury, NJ 08512